Search

Author/Creator El-Adl, Khaled

1. 1, 2, 4-Triazolo[4, 3-c]quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity. (8th June 2021)

Authors:
El-Shershaby, Mohamed H.; Ghiaty, Adel; Bayoumi, Ashraf H.; Ahmed, Hany E. A.; El-Zoghbi, Mona S.; El-Adl, Khaled; Abulkhair, Hamada S.
Journal:
New journal of chemistry
Issue:
Volume 45:Number 25(2021)
Page Start:
11136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. [1, 2, 4]Triazolo[4, 3-a]quinoxaline and [1, 2, 4]triazolo[4, 3-a]quinoxaline-1-thiol-derived DNA intercalators: design, synthesis, molecular docking, in silico ADMET profiles and anti-proliferative evaluations. (23rd December 2020)

Authors:
El-Adl, Khaled; El-Helby, Abdel-Ghany A.; Sakr, Helmy; Elwan, Alaa
Journal:
New journal of chemistry
Issue:
Volume 45:Number 2(2021)
Page Start:
881
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. [1, 2, 4]Triazolo[4, 3-a]quinoxaline and [1, 2, 4]triazolo[4, 3-a]quinoxaline-1-thiol-derived DNA intercalators: design, synthesis, molecular docking, in silico ADMET profiles and anti-proliferative evaluations. (23rd December 2020)

Authors:
El-Adl, Khaled; El-Helby, Abdel-Ghany A.; Sakr, Helmy; Elwan, Alaa
Journal:
New journal of chemistry
Issue:
Volume 45:Number 2(2021)
Page Start:
881
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. [1, 2, 4]Triazolo[4, 3-c]quinazoline and bis([1, 2, 4]triazolo)[4, 3-a:4′, 3′-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies. (15th January 2021)

Authors:
El-Adl, Khaled; Ibrahim, Mohamed-Kamal; Alesawy, Mohammed S.I.; Eissa, Ibrahim H.
Journal:
Bioorganic & medicinal chemistry
Issue:
Volume 30(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors. (1st January 2021)

Authors:
El-Adl, Khaled; El-Helby, Abdel-Ghany A.; Ayyad, Rezk R.; Mahdy, Hazem A.; Khalifa, Mohamed M.; Elnagar, Hamdy A.; Mehany, Ahmed B.M.; Metwaly, Ahmed M.; Elhendawy, Mostafa A.; Radwan, Mohamed M.; ElSohly, Mahmoud A.; Eissa, Ibrahim H.
Journal:
Bioorganic & medicinal chemistry
Issue:
Volume 29(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The antimicrobial potential and pharmacokinetic profiles of novel quinoline-based scaffolds: synthesis and in silico mechanistic studies as dual DNA gyrase and DHFR inhibitors. (20th July 2021)

Authors:
El-Shershaby, Mohamed H.; El-Gamal, Kamal M.; Bayoumi, Ashraf H.; El-Adl, Khaled; Alswah, Mohamed; Ahmed, Hany E. A.; Al-Karmalamy, Ahmed A.; Abulkhair, Hamada S.
Journal:
New journal of chemistry
Issue:
Volume 45:Number 31(2021)
Page Start:
13986
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations. (31st December 2022)

Authors:
Elwan, Alaa; Sakr, Helmy; El-Helby, Abdel-Ghany A.; El-morsy, Ahmed; Abdelgawad, Mohamed A.; Ghoneim, Mohammed M.; El-Sherbiny, Mohamed; El-Adl, Khaled
Journal:
Journal of enzyme inhibition and medicinal chemistry
Issue:
Volume 37:Number 1(2022)
Page Start:
1556
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗